Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James O. Kilburn is active.

Publication


Featured researches published by James O. Kilburn.


Antimicrobial Agents and Chemotherapy | 1979

Inhibition by Ethambutol of Mycolic Acid Transfer into the Cell Wall of Mycobacterium smegmatis

Kuni Takayama; Emma Lee Armstrong; Keith A. Kunugi; James O. Kilburn

Ethambutol simultaneously inhibited the transfer (presumably via mycolyl acetyl trehalose) of mycolic acids into the cell wall and stimulated the synthesis of trehalose dimycolates of Mycobacterium smegmatis. Structural similarities of the drug and mycolyl acetyl trehalose suggested that competitive inhibition was involved.


Antimicrobial Agents and Chemotherapy | 1977

Effect of Ethambutol on the Viable Cell Count in Mycobacterium smegmatis

James O. Kilburn; Joseph Greenberg

Soon after a strain of Mycobacterium smegmatis was exposed to ethambutol (EMB), the number of viable cells increased dramatically above the number in a drug-free control. This rapid rise did not occur when the culture was maintained at 4°C instead of 37°C, when an EMB-resistant mutant was used, when auxotrophs were exposed in medium lacking nutrients essential for growth, nor when the levo form of EMB was used. EMB caused no increase in deoxyribonucleic acid synthesis, nor in septum formation of dividing cells. Treated cells changed morphologically, resulting in a lower surface area-to-volume ratio. Whereas EMB did not eliminate cell clusters, the cluster size decreased markedly as detected by filtration and Coulter counter measurements. We concluded that EMB causes a reduced surface-to-volume ratio, leading to reduced cell cohesion and a consequent reduction in cluster size, reflected in an increase in colony-forming units. Images


Antimicrobial Agents and Chemotherapy | 1981

Effects of Ethambutol on Phospholipid Metabolism in Mycobacterium smegmatis

James O. Kilburn; Kuni Takayama; Emma Lee Armstrong; Joseph Greenberg

Soon after Mycobacterium smegmatis was exposed to ethambutol, the synthesis of cardiolipin and phosphatidylinositol dimannoside declined. The synthesis of phosphatidylethanolamine continued, but the drug caused this phospholipid to leak out of the cells.


International Journal of Systematic and Evolutionary Microbiology | 1970

DIFFERENTIAL IDENTIFICATION OF MYCOBACTERIA VI. MYCOBACTERIUM TRIVIALE KUBICA SP. NOV.

George P. Kubica; Vella A. Silcox; James O. Kilburn; Ronald W. Smithwick; R. Edward Beam; Wilbur D. Jones; K. D. Stottmeier

ABSTRACT A new species of nonphot ochromogen mycobacteria is described. Most of the strains examined have been isolated from man; however, because of their lack of relationship to human disease, the name Mycobacterium triviale Kubica is proposed. The physical and biochemical characteristics, serologic activity, and thin layer chromatographic pattern of this new species serve to distinguish it from other nonphotochromo-genic mycobacteria in Runyons Group III.


Antimicrobial Agents and Chemotherapy | 1972

Susceptibility of Mycobacteria to Rifampin

Charles L. Woodley; James O. Kilburn; Hugo L. David; Vella A. Silcox

The Mycobacterium species M. tuberculosis, M. avium-intracellulare, M. kansasii, M. marinum, M. scrofulaceum, M. fortuitum, M. terrae, and M. gordonae were analyzed for their susceptibility to rifampin. M. tuberculosis, M. kansasii, and M. marinum were susceptible to the antibiotic, and resistant populations developed as a result of the interplay of mutation and selection. The mutation rates (susceptibility → resistance) were calculated to be 4.9 × 10−10 and 1.7 × 10−9 mutations per bacterium per generation in, respectively, M. kansasii and M. marinum. M. fortuitum was found to be naturally resistant to the antibiotic, whereas the nature of resistance in the other species was unclear and is discussed.


The Journal of Infectious Diseases | 1993

Transmission of Multidrug-Resistant Mycobacterium tuberculosis among Persons with Human Immunodeficiency Virus Infection in an Urban Hospital: Epidemiologic and Restriction Fragment Length Polymorphism Analysis

Victor G. Coronado; Consuelo M. Beck-Sague; Mary D. Hutton; Barry J. Davis; Peter Nicholas; Carmelita Villareal; Charles L. Woodley; James O. Kilburn; Jack T. Crawford; Thomas R. Frieden; Ronda L. Sinkowitz; William R. Jarvis


The Journal of Infectious Diseases | 1994

Multidrug-Resistant Tuberculosis in the New York State Prison System, 1990–1991

Sarah E. Valway; Robert B. Greifinger; Mark J. Papania; James O. Kilburn; Charles L. Woodley; George T. DiFerdinando; Samuel W. Dooley


The American review of respiratory disease | 2015

Infection and Disease Among Contacts of Tuberculosis Cases with Drug-Resistant and Drug-Susceptible Bacilli1,2

Dixie E. Snider; Gloria D. Kelly; George M. Cauthen; Nancy J. Thompson; James O. Kilburn


Annals of Internal Medicine | 1994

Clinical and Epidemiologic Characteristics of Mycobacterium haemophilum, an Emerging Pathogen in Immunocompromised Patients

Walter L. Straus; Stephen M. Ostroff; Daniel B. Jernigan; Timothy E. Kiehn; Emilia M. Sordillo; Donald Armstrong; Natalie Boone; Nancy Schneider; James O. Kilburn; Vella A. Silcox; Vincent LaBombardi; Robert C. Good


The American review of respiratory disease | 2015

In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.

Charles L. Woodley; James O. Kilburn

Collaboration


Dive into the James O. Kilburn's collaboration.

Top Co-Authors

Avatar

Charles L. Woodley

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

George P. Kubica

United States Public Health Service

View shared research outputs
Top Co-Authors

Avatar

Vella A. Silcox

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Robert C. Good

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Dixie E. Snider

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Emma Lee Armstrong

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

K. D. Stottmeier

United States Public Health Service

View shared research outputs
Top Co-Authors

Avatar

Kuni Takayama

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Laurence S. Farer

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge